No Data
US In-Vitro Diagnostics Market Forecast Report and Company Analysis 2025-2033 Featuring Roche Diagnostics, Danaher, Thermofisher Scientific, Bio-Rad, Biomerieux, Abbott Laboratories, Sysmex - ResearchAndMarkets.com
Hematology Diagnostics Industry Forecast to Grow From $4.06 Billion in 2024 to $5.93 Billion by 2030 - Abbott, Beckman Coulter, Sysmex Corp, Roche, and Siemens Healthineers Lead the Competition
TBS HD, NTV HD, etc. (additional) Rating
Upgraded - Bullish Code Name Securities Company Previous Changes After --------------------------------------------------------- <5110> Sumitomo Rubbers City "2" "1" Downgraded - Bearish Code Name Securities Company Previous Changes After --------------------------------------------------------- <7974> NINTENDO CO LTD Morgan Stanley "Overweight" "Equal Weight"
Sysmex America Expands Operations With Plans for New Reagent Manufacturing, Distribution and Service Center in Brazil
Optim Research Memo (1): Developing services utilizing generative AI across various fields. Strong performance in the interim period for the fiscal year ending March 2025 (1).
■Summary OPTiM <3694> is a venture company that specializes in AI and IoT technologies. It aims to play a central role in the Fourth Industrial Revolution through the de facto standardization of its main products, "Optimal Biz" and "OPTiM Cloud IoT OS." From the beginning, it has focused on developing technologies to create services that do not exist in the world, and it owns numerous related patents (1,129 applications, 548 registrations, as of March 2024).
Tosei, Aeon Delaire, Etc (additional) Rating
Upgraded - Bullish Ticker Symbol Company Name Brokerage Firm Previous Change After --------------------------------------------------- <7735> Screen Mizuho "Hold" "Buy" Downgraded - Bearish Ticker Symbol Company Name Brokerage Firm Previous Change After --------------------------------------------------- <6586> Makita GS "Buy" "Hold" <6857> Advante Mizuho "Buy"